ATE459718T1 - Neue chimärische plasminogenaktivatoren und deren pharmazeutische verwendung - Google Patents

Neue chimärische plasminogenaktivatoren und deren pharmazeutische verwendung

Info

Publication number
ATE459718T1
ATE459718T1 AT03782451T AT03782451T ATE459718T1 AT E459718 T1 ATE459718 T1 AT E459718T1 AT 03782451 T AT03782451 T AT 03782451T AT 03782451 T AT03782451 T AT 03782451T AT E459718 T1 ATE459718 T1 AT E459718T1
Authority
AT
Austria
Prior art keywords
activationers
pharmaceutical use
terminally
new chimeric
plasminogen activator
Prior art date
Application number
AT03782451T
Other languages
English (en)
Inventor
Werner Seeger
Andreas Guenther
Clemens Ruppert
Philipp Markart
Viktor Magdolen
Timothy E Weaver
Original Assignee
Univ Giessen Justus Liebig
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Giessen Justus Liebig filed Critical Univ Giessen Justus Liebig
Application granted granted Critical
Publication of ATE459718T1 publication Critical patent/ATE459718T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT03782451T 2003-12-18 2003-12-18 Neue chimärische plasminogenaktivatoren und deren pharmazeutische verwendung ATE459718T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2003/014542 WO2005059142A1 (en) 2003-12-18 2003-12-18 Novel chimeric plasminogen activators and their pharmaceutical use

Publications (1)

Publication Number Publication Date
ATE459718T1 true ATE459718T1 (de) 2010-03-15

Family

ID=34684504

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03782451T ATE459718T1 (de) 2003-12-18 2003-12-18 Neue chimärische plasminogenaktivatoren und deren pharmazeutische verwendung

Country Status (9)

Country Link
US (1) US8124588B2 (de)
EP (1) EP1694848B1 (de)
JP (1) JP4505416B2 (de)
AT (1) ATE459718T1 (de)
AU (1) AU2003290092B2 (de)
CA (1) CA2588965C (de)
DE (1) DE60331601D1 (de)
ES (1) ES2342055T3 (de)
WO (1) WO2005059142A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007047995A2 (en) 2005-10-21 2007-04-26 Catalyst Biosciences, Inc. Modified proteases that inhibit complement activation
US9289388B2 (en) 2008-12-10 2016-03-22 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2012017310A2 (en) * 2010-08-05 2012-02-09 Council Of Scientific & Industrial Research Protein fusion constructs possessing thrombolytic and anticoagulant properties
CN104755502B (zh) * 2012-10-12 2018-05-18 清华大学 多肽的产生和纯化方法
CA2914306A1 (en) * 2013-06-24 2014-12-31 Azargen Biotechnologies (Pty) Ltd Production of human pulmonary surfactant protein b in plants
WO2021180068A1 (zh) * 2020-03-09 2021-09-16 泰伦基国际有限公司 一种治疗2019新型冠状病毒引发疾病的方法和药物
US20210322511A1 (en) * 2020-04-17 2021-10-21 President And Fellows Of Harvard College Methods and compositions for treating a respiratory disease
IT202300008805A1 (it) * 2023-05-04 2024-11-04 Cerbios Pharma Sa Metodo per la produzione di urochinasi ricombinante umana a basso peso molecolare farmaceuticamente attiva

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112755A (en) 1982-04-15 1992-05-12 Genentech, Inc. Preparation of functional human urokinase proteins
GB8334498D0 (en) 1983-12-24 1984-02-01 Beecham Group Plc Compounds
US4880776A (en) 1983-12-24 1989-11-14 Beecham Group P.L.C. Plasmin A-chain urokinase B-chain hybrid protein
US5242819A (en) 1986-12-05 1993-09-07 Ciba-Geigy Corporation DNA molecules encoding hybrid proteins of tissue plasminogen activator and urokinase
US4999194A (en) 1988-01-14 1991-03-12 Collaborative Research, Inc. Two-chain urokinase plasminogen activators for treatment of thrombotic disease
US5006343A (en) 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5238920A (en) 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
US6031075A (en) 1996-02-05 2000-02-29 Children's Hospital Medical Center Mature alveolar SP-B and a process for producing the same
WO2000029588A1 (en) * 1998-11-18 2000-05-25 Children's Hospital Medical Center Lysozyme fusion proteins in infections
US5993809A (en) 1998-11-18 1999-11-30 Children's Hospital Medical Center Lysozyme fusion proteins in infections
EP1189625A1 (de) 1999-06-11 2002-03-27 Byk Gulden Lomberg Chemische Fabrik GmbH Pharmazeutische zubereitung enthaltend modifikationen von surfactant protein b (sp-b) und surfactant protein c (sp-c)

Also Published As

Publication number Publication date
EP1694848B1 (de) 2010-03-03
AU2003290092A1 (en) 2005-07-05
JP2008500001A (ja) 2008-01-10
US20090305961A1 (en) 2009-12-10
AU2003290092B2 (en) 2009-11-19
EP1694848A1 (de) 2006-08-30
DE60331601D1 (de) 2010-04-15
WO2005059142A1 (en) 2005-06-30
US8124588B2 (en) 2012-02-28
JP4505416B2 (ja) 2010-07-21
CA2588965C (en) 2013-01-22
ES2342055T3 (es) 2010-07-01
CA2588965A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
ATE510011T1 (de) Neue pilzproteine und diese codierende nukleinsäuren
WO2005024044A3 (en) Method for the production of fusion proteins in transgenic mammal milk
ATE444361T1 (de) Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
MX2009005304A (es) Polipeptidos heterodimericos il-17a/f y usos terapeuticos de los mismos.
ATE385806T1 (de) Fusionsproteine
MX2008001865A (es) Proteinas de fusion de albumina.
BRPI0207394B8 (pt) dna codificando uma proteína de fusão proteína codificada por um dna, plasmídeo, micro-organismo hospedeiro, processo para a produção fermentativa de uma proteína de fusão e processo para a produçao de insulina
BRPI0416807A (pt) sistemas de expressão aperfeiçoados com secreção de sistema sec
WO2005010044A3 (en) Il-17 a/f heterologous polypeptides and therapeutic uses thereof
ATE513043T1 (de) Gegen denaturierungsmittel stabile und/oder proteaseresistente, chaperonähnliche oligomere proteine, diese kodierende polynukleotide sowie ihre verwendungen
ATE459718T1 (de) Neue chimärische plasminogenaktivatoren und deren pharmazeutische verwendung
MY158159A (en) Novel fused pyrrolocarbazoles
ATE448312T1 (de) Leitsequenzen zur verwendung bei der produktion von proteinen
UA91820C2 (ru) Терапевтическое применение вариантов хемокинов
YU91403A (sh) Antitela specifična za cd44v6
KR20090071852A (ko) 배트록소빈의 변이 뉴클레오타이드 서열, α－인자 분비 시그널 서열 변이체 및 이를 이용한 재조합 단백질의 제조방법및 이를 이용한 배트록소빈의 제조방법
WO2002016611A3 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
NO20053033D0 (no) Anvendelse av caspase enzymer for modning av konstruerte rekombinante polypeptidfusjoner.
ATE539086T1 (de) Interleukin-11-fusionsproteine
EE200300265A (et) Glükuronüül-C5-epimeraas, seda kodeeriv DNA ja selle kasutamine
KR20220150345A (ko) 프로테아제-처리 분자
CN100424172C (zh) 一种定向突变的基因工程巴曲酶及用途
WO2006025995A3 (en) Compositions and methods using md-2 mutants and chimeric proteins
EA201070372A1 (ru) СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО с-ПЕПТИДА ПРОИНСУЛИНА ЧЕЛОВЕКА
DK1472342T3 (da) Med OXA1P forbedret proteinsekretion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties